This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Krpski, W. C. Articles by Harker, L. A. Search for Related Content PubMed PubMed Citation Articles by Krpski, W. C. Articles by Harker, L. A.

Circulation, Vol 82, 570-577, Copyright © 1990 by American Heart Association

ARTICLES

Heparin-resistant thrombus formation by endovascular stents in baboons. Interruption by a synthetic antithrombin

WC Krpski, A Bass, AB Kelly, UM Marzec, SR Hanson and LA Harker
Department of Basic and Clinical Research, Scripps, Clinic and Research Foundation, La Jolla, California.

Intravascular mechanical support has been proposed as a solution to the frequent occurrence of vascular narrowing and occlusion after transluminal balloon angioplasty or surgical endarterectomy. Although several endovascular stents are currently in clinical use for angioplasty of larger vessels, acute thrombosis is a troublesome complication of their use with coronary angioplasty. To study thrombus formation associated with metallic mesh endoprostheses, we have evaluated stents placed inside 3-mm expanded polytetrafluoroethylene (ePTFE) grafts incorporated into chronic exteriorized arteriovenous silicone rubber shunts in baboons. We have also compared the antithrombotic capacities of heparin and the synthetic antithrombin D- phenylalanyl-L-prolyl-L-arginyl-chloromethylkene (D-FPRCH2Cl) to interrupt this platelet-dependent process for two different endovascular stents. Acute platelet deposition was continuously measured during 1 hour using gamma camera imaging of platelets labeled with indium-111 oxine. On untreated control ePTFE grafts (n = 11), 0.87 +/- 0.15 x 10(9) platelets/cm were deposited during 60 minutes. In contrast, balloon-expandable endovascular stents within ePTFE (n = 6) accumulated 4.37 +/- 0.68 x 10(9) platelets/cm (p = 0.003 compared with controls), and self-expandable stents (n = 6) accumulated 3.91 +/- 0.42 x 10(9) platelets/cm (p = 0.006 compared with controls); no difference between stents was detected in this test system (p greater than 0.5). Systemic heparin treatment did not reduce platelet deposition (4.20 +/- 0.41 x 10(9) platelets/cm at 60 minutes; p greater than 0.5).(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				A. I. Qureshi Editorial Comment--Thromboembolic Events During Neuroendovascular Procedures Stroke, July 1, 2003; 34(7): 1728 - 1729. [Full Text] [PDF]

				T. Palmerini, M. A. Nedelman, L. E. Scudder, M. T. Nakada, R. E. Jordan, S. Smyth, R. E. Gordon, J. T. Fallon, and B. S. Coller Effects of abciximab on the acute pathology of blood vessels after arterial stenting in nonhuman primates J. Am. Coll. Cardiol., July 17, 2002; 40(2): 360 - 366. [Abstract] [Full Text] [PDF]

				P. A. Hardhammar, H. M.M. van Beusekom, H. U. Emanuelsson, S. H. Hofma, P. A. Albertsson, P. D. Verdouw, E. Boersma, P. W. Serruys, and W. J. van der Giessen Reduction in Thrombotic Events With Heparin-Coated Palmaz-Schatz Stents in Normal Porcine Coronary Arteries Circulation, February 1, 1996; 93(3): 423 - 430. [Abstract] [Full Text]

				T. Yokoyama, A. B. Kelly, U. M. Marzec, S. R. Hanson, S. Kunitada, and L. A. Harker Antithrombotic Effects of Orally Active Synthetic Antagonist of Activated Factor X in Nonhuman Primates Circulation, August 1, 1995; 92(3): 485 - 491. [Abstract] [Full Text]

				J. J. Cook, G. R. Sitko, B. Bednar, C. Condra, M. J. Mellott, D.-M. Feng, R. F. Nutt, J. A. Shafer, R. J. Gould, and T. M. Connolly An Antibody Against the Exosite of the Cloned Thrombin Receptor Inhibits Experimental Arterial Thrombosis in the African Green Monkey Circulation, June 15, 1995; 91(12): 2961 - 2971. [Abstract] [Full Text]